Sugii S, Ohishi I, Sakaguchi G
Infect Immun. 1977 Jun;16(3):910-4. doi: 10.1128/iai.16.3.910-914.1977.
The in vitro sensitivity to acid and pepsin differed markedly among Clostridium botulinum type A and B toxins of different molecular sizes. The larger the molecular size of the toxin, the higher the resistance to these agents. Tye B derivative toxin was rapidly inactivated, but the progenitor toxins resisted in vitro exposure to rat intestinal juice. The molecular dissociation of the progenitor toxins did not occur in rat intestinal juice of pH 7.0, but did occur in a buffer solution of the same pH. The oral toxicity may depend mostly on the stability of toxin molecules in the stomach and, to a less extent, in the intestine. The present results seem to justify the conclusion that C. botulinum type A and B progenitor toxins with molecular sizes larger than 16S are more potent oral toxins than 12S progenitor toxins.
不同分子大小的A型和B型肉毒梭菌毒素对酸和胃蛋白酶的体外敏感性差异显著。毒素的分子大小越大,对这些物质的抵抗力越高。B型衍生毒素迅速失活,但原始毒素能抵抗体外大鼠肠液的作用。原始毒素在pH 7.0的大鼠肠液中不会发生分子解离,但在相同pH值的缓冲溶液中会发生解离。口服毒性可能主要取决于毒素分子在胃中的稳定性,在肠道中的稳定性影响较小。目前的结果似乎证明了这样的结论:分子大小大于16S的A型和B型肉毒梭菌原始毒素比12S原始毒素更具强效口服毒素。